Ferroquine二茂铁氯喹,185055-67-8

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Ferroquine

CAS No. : 185055-67-8

MCE 国际站：Ferroquine

产品活性：Ferroquine (Ferrochloroquine)，是 Chloroquine 的二茂铁基类似物，是一种抗疟疾剂。Ferroquine 通过诱导氧化应激和随后的膜破坏而对疟原虫表现出杀虫作用。

研究领域：Anti-infection

作用靶点：Parasite

In Vitro: Ferroquine shows cytotoxicity against non-cancerous MRC-5 and HeLa cancer cells with IC₅₀ values of 24.4 µM and 16.8 µM, respectively.
24 hours post-incubation all newly transformed schistosomula (NTS) exposed to 33.3 µM Ferroquine shows strongly reduced viabilities.

In Vivo: Treatment of mice with 200 and 800 mg/kg Ferroquine, shows low total worm burden reductions of 19.4% and 35.6%. One of the mice treated with 800 mg/kg Ferroquine died within 24 hours post-treatment. No activity is observed treating mice with RQ at 200 mg/kg. Finally, a total worm burden reduction of 17.3% is observed following treatment with FQ-OH. Hence, modification of Chloroquine (CQ) by a ferrocenyl or ruthenocenyl fragment does not increase the antischistosomal properties of CQ. For comparison, at 200 mg/kg mefloquine (MQ) achieves a much higher worm burden reduction of 72.3% in S. mansoni-infected mice. A higher effect against female adult S. mansoni is also observed in MQ treated mice pointing to a sex-specific interference of these drugs with the target. Furthermore, in one of the FQ-OH treated mice many dead worms are recovered and a hepatic shift (i.e. worms migrating to the liver) observed. Hence, Ferroquine and FQ-OH show weak antischistosomal activity in vivo.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  Clinical Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Oxygen Sensing Compound Library  |  Antiparasitic Compound library  |  Anti-Parkinson's Disease Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Chloroquine  |  Hydroxychloroquine sulfate  |  Kaempferol  |  Metronidazole  |  Dihydroartemisinin  |  Ivermectin  |  Niclosamide  |  Artesunate  |  Eflornithine hydrochloride hydrate  |  Suramin sodium salt  |  Artemisinin  |  Halofuginone  |  Quinidine  |  Miransertib  |  RRx-001  |  Doxycycline  |  Nitazoxanide  |  Atovaquone  |  Obatoclax Mesylate  |  Quinacrine dihydrochloride  |  Diminazene aceturate  |  Flufenamic acid  |  Methylene Blue  |  Osthole  |  Mebendazole  |  PK 11195  |  Quinine  |  Dehydrocorydaline

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物  |  寡核苷酸

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种TOP期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪前沿的制药及生命科学研究进展，为您提供全球前沿的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。